Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIF

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. It also provides analytical services.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc

<< Previous

Bullboard Posts

Next >>

Post by NOPAINNOGAIN123on Oct 11, 2018 12:35pm

151 Views

Post# 28781841

Unbelievable

10/11/2018	1.48	1.92	1.21	1.25	255.1k	-0.16	-11.35%	1.25	408.37k	1,080
10/10/2018	1.75	2.28	1.34	1.41	57.09k	-0.32	-18.50%	1.41	101.25k	401
10/09/2018	1.90	1.90	1.66	1.73	20.55k	-0.29	-14.36%	1.73	37.03k	91
10/05/2018	2.90	2.90	1.98	2.02	47.53k	-0.90	-30.82%	2.02	106.59k	223
10/04/2018	2.90	2.97	2.90	2.92	2.77k	-0.04	-1.35%	2.92	8.12k	21
10/03/2018	3.15	3.18	2.94	2.96	3.99k	-0.17	-5.43%	2.96	12.07k	37
10/02/2018	3.26	3.26	3.13	3.13	5.4k	-0.14	-4.28%	3.13	17.22k	44
10/01/2018	3.45	3.45	3.27	3.27	1.9k	-0.19	-5.49%	3.27	6.36k	19
09/28/2018	3.67	3.67	3.46	3.46	1.6k	-0.22	-5.98%	3.46	5.66k	15
09/27/2018	3.87	3.88	3.64	3.68	6.13k	-0.31	-7.77%	3.68	22.83k	52
09/26/2018	4.22	4.22	3.96	3.99	5.6k	-0.24	-5.67%